Private placement
Cellexus Biosystems plc has raised £400,000 in a private placing to
accelerate the commercialisation of its disposable bioreactor
technology. The company, based in March, Cambridgeshire has now raised
£900,000 since its formation in December 2005.
Cellexus’ technology offers considerable advantages to biopharmaceutical manufacturers, as the remove the need to clean down equipment between process runs, not only saving time, but eliminating many quality control issues. In addition, the reactors are designed to promote natural circulation of the reactants, removing the need for process mixtures to be mechanically stirred.
www.cellexusbiosystems.com
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening. 
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.
